|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
|
|---|---|---|
| Operating expenses | ||
| General and administrative | ||
| Research and development | ||
| Change in fair value of contingent consideration | ||
| Loss from operations | ||
| Other income | ||
| Net loss | ||
| Net loss per share of common stock: | ||
| Basic | ||
| Diluted | ||
| Weighted-average shares of common stock outstanding: | ||
| Basic | ||
| Diluted |
Loading...
